Trial ID: | L0971 |
Source ID: | NCT00214721
|
Associated Drug: |
Experimental Peritoneal Dialysis Solution
|
Title: |
A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis
|
Acronym: |
|
Status: |
COMPLETED
|
Study Results: |
NO
|
Results: |
|
Conditions: |
End Stage Renal Disease
|
Interventions: |
DRUG: Experimental Peritoneal Dialysis Solution
|
Outcome Measures: |
|
Sponsor/Collaborators: |
Sponsor: Vantive Health LLC | Collaborators: Baxter Healthcare Corporation
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
PHASE3
|
Enrollment: |
120
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
Start Date: |
2005-02
|
Completion Date: |
2006-07
|
Results First Posted: |
|
Last Update Posted: |
2025-03-03
|
Locations: |
St. Paul's Hospital, Vancouver, British Columbia, V6Z 1Y6, Canada
|
URL: |
https://clinicaltrials.gov/show/NCT00214721
|